CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,608,000 | -28.5% | 900,000 | 0.0% | 0.18% | -21.0% |
| Q2 2019 | $6,444,000 | -32.1% | 900,000 | +25.9% | 0.23% | -36.3% |
| Q1 2019 | $9,495,000 | +96.6% | 715,000 | +16.5% | 0.37% | +60.5% |
| Q4 2018 | $4,829,000 | -29.0% | 613,604 | 0.0% | 0.23% | -7.3% |
| Q3 2018 | $6,799,000 | -12.7% | 613,604 | +5.8% | 0.25% | -18.0% |
| Q2 2018 | $7,784,000 | +22.3% | 580,000 | +18.4% | 0.30% | +10.3% |
| Q1 2018 | $6,365,000 | +53.7% | 490,000 | +8.9% | 0.27% | +44.7% |
| Q4 2017 | $4,140,000 | +14.1% | 450,000 | 0.0% | 0.19% | +12.6% |
| Q3 2017 | $3,627,000 | +269.0% | 450,000 | +350.0% | 0.17% | +45.2% |
| Q4 2014 | $983,000 | -52.1% | 100,000 | -66.7% | 0.12% | -63.7% |
| Q3 2014 | $2,052,000 | – | 300,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |